Eukles Asset Management Resmed Inc Transaction History

Eukles Asset Management

$244 Million
Q3 2024

A detailed history of Eukles Asset Management transactions in Resmed Inc stock. As of the latest transaction made, Eukles Asset Management holds 23,266 shares of RMD stock, worth $5.46 Million. This represents 2.32% of its overall portfolio holdings.

Number of Shares

23,266

Previous 23,355 0.38%

Holding current value

$5.46 Million

Previous $4.47 Million 27.05%

% of portfolio

2.32%

Previous 1.97%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$186.94 - $252.92 $16,637 - $22,509	-89 Reduced 0.38%	23,266 $5.68 Million
Q2 2024 Aug 01, 2024	BUY	$173.83 - $220.63 $15,123 - $19,194	87 Added 0.37%	23,355 $4.47 Million
Q1 2024 May 13, 2024	BUY	$165.79 - $198.03 $148,382 - $177,236	895 Added 4.0%	23,268 $4.61 Million
Q4 2023 Jan 31, 2024	BUY	$134.65 - $174.81 $1,346 - $1,748	10 Added 0.04%	22,373 $3.85 Million
Q3 2023 Oct 25, 2023	BUY	$136.29 - $225.35 $36,798 - $60,844	270 Added 1.22%	22,363 $3.31 Million
Q2 2023 Aug 01, 2023	BUY	$209.98 - $240.96 $36,116 - $41,445	172 Added 0.78%	22,093 $4.83 Million
Q1 2023 Apr 28, 2023	SELL	$205.07 - $236.53 $17,225 - $19,868	-84 Reduced 0.38%	21,921 $4.8 Million
Q4 2022 Jan 27, 2023	BUY	$205.77 - $233.97 $88,275 - $100,373	429 Added 1.99%	22,005 $4.58 Million
Q3 2022 Oct 28, 2022	SELL	$212.32 - $243.58 $3,609 - $4,140	-17 Reduced 0.08%	21,576 $4.71 Million
Q2 2022 Jul 28, 2022	BUY	$191.41 - $252.08 $27,371 - $36,047	143 Added 0.67%	21,593 $4.53 Million
Q1 2022 Apr 27, 2022	SELL	$216.12 - $261.47 $122,972 - $148,776	-569 Reduced 2.58%	21,450 $5.2 Million
Q4 2021 Feb 10, 2022	BUY	$248.03 - $268.66 $66,472 - $72,000	268 Added 1.23%	22,019 $5.74 Million
Q3 2021 Oct 28, 2021	BUY	$247.68 - $297.36 $291,271 - $349,695	1,176 Added 5.72%	21,751 $5.73 Million
Q2 2021 Jul 27, 2021	BUY	$187.97 - $247.09 $254,511 - $334,559	1,354 Added 7.04%	20,575 $5.07 Million
Q1 2021 Apr 27, 2021	BUY	$179.46 - $222.28 $139,978 - $173,378	780 Added 4.23%	19,221 $3.73 Million
Q4 2020 Jan 26, 2021	BUY	$167.5 - $220.59 $54,102 - $71,250	323 Added 1.78%	18,441 $3.92 Million
Q3 2020 Oct 29, 2020	BUY	$168.14 - $205.63 $29,256 - $35,779	174 Added 0.97%	18,118 $3.11 Million
Q2 2020 Jul 29, 2020	BUY	$142.29 - $192.0 $101,168 - $136,512	711 Added 4.13%	17,944 $3.45 Million
Q1 2020 Apr 22, 2020	SELL	$114.34 - $176.62 $86,212 - $133,171	-754 Reduced 4.19%	17,233 $2.54 Million
Q4 2019 Jan 24, 2020	SELL	$126.52 - $156.7 $10,754 - $13,319	-85 Reduced 0.47%	17,987 $2.79 Million
Q3 2019 Oct 29, 2019	SELL	$123.37 - $140.33 $4,194 - $4,771	-34 Reduced 0.19%	18,072 $2.44 Million
Q2 2019 Aug 01, 2019	SELL	$97.37 - $123.27 $6,913 - $8,752	-71 Reduced 0.39%	18,106 $2.21 Million
Q1 2019 Apr 23, 2019	BUY	$91.56 - $117.84 $13,276 - $17,086	145 Added 0.8%	18,177 $1.89 Million
Q4 2018 Jan 22, 2019	BUY	$98.06 - $115.33 $1.77 Million - $2.08 Million	18,032 New	18,032 $2.05 Million

Others Institutions Holding RMD

# of Institutions

891

Shares Held

80.9M

Call Options Held

913K

Put Options Held

2.39M

View Full List

About RESMED INC

Ticker RMD
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 146,459,008
Market Cap $34.4B

More about RMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eukles Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Eukles Asset Management with notifications on news.

Account

Eukles Asset Management Resmed Inc Transaction History